TTAM Research Institute's court-approved purchase of bankrupt 23andMe (genetic database, testing and research businesses)
$305 million
USD for the whole company (one transaction), US
“A federal bankruptcy court has approved the sale of consumer genetics testing firm 23andMe to TTAM Research Institute ... As part of TTAM's $305 million bid, it promised to uphold the consumer genetics testing firm's current privacy policies and implement additional data safeguards.”
GovInfoSecurity (ISMG), Court Approves 23andMe Sale to TTAM Research Institute (2 July 2025), 2025-07
- Kind of source
- Named press report
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- A whole-company distressed sale that replaced Regeneron's earlier $256 million agreement; it bought the brand, the lab, the research business and the database, not data alone.
- About
- Consumer DNA test
Used in
Kept as evidence; no figure on the platform is computed from it yet.
Replaces an earlier figure: $256 million (Quartz, 23andMe just got bought out of bankruptcy (May 2025), 2025-05)